Supplemental material, sj-jpg-15-npx-10.1177_1934578X221130874 for Cryptotanshinone From Salvia miltiorrhiza Inhibits the Growth of Tumors and Enhances the Efficacy of Chemotherapy in a Gastric Cancer Mouse Model by Wenkai Wu, Yezhi Cao, Ling Cheng, Linghu Wang, Qingsheng Yu, Hui Peng, Fuhai Zhou, Haiwei Liu and Qi Zhang in Natural Product Communications

Supplemental material, sj-jpg-16-npx-10.1177_1934578X221130874 for Cryptotanshinone From Salvia miltiorrhiza Inhibits the Growth of Tumors and Enhances the Efficacy of Chemotherapy in a Gastric Cancer Mouse Model by Wenkai Wu, Yezhi Cao, Ling Cheng, Linghu Wang, Qingsheng Yu, Hui Peng, Fuhai Zhou, Haiwei Liu and Qi Zhang in Natural Product Communications

Additional file 2: Supplemental Figure 2. Situation of affectorcells and target cells (HOS, Saos-2, SW1353) displayed by optical microscopy.

Additional file 1: Figure S1. The distribution comparison of Candida species isolated from mixed C/B-BSIs and mono-candidemia. Mono-candidemia, monomicrobial candidemia; Mixed C/B-BSIs, mixed Candida/bacterial bloodstream infections.

Additional file 8: Figure S6. Relationship among risk scores and clinical characteristics. Correlations of risk scores and A age, B sex, C T stage, D N stage, E metastatic status, F total stage, G immune score, and H Clusters. ns, not significant; *p < 0.05, **p < 0.01, and ***p < 0.001.

Supplemental material, sj-tif-5-tej-10.1177_20417314221132093 for A new cell-free therapeutic strategy for liver regeneration: Human placental mesenchymal stem cell-derived extracellular vesicles by Ting Li, Yu Fu, Zeyi Guo, Honglei Zhu, Hangyu Liao, Xiaoge Niu, Lin Zhou, Shunjun Fu, Yang Li, Shao Li, Lujia Wang, Yizhou Zheng, Lei Feng, Yi Gao and Guolin He in Journal of Tissue Engineering

Supplementary Material 1

Supplementary Material 2

Additional file 7: Biological process enrichment of common and variety-specific regulated genes.

Additional file 4: Fig. S4. Effects of cilostazol treatment on complete blood counts after CLP. a, b The level of platelets (a), WBC (b), NEUT (c), MONO (d) and LYMPH (e) (n = 5). WBC, white blood cells; NEUT, neutrophil; MONO, monocyte; LYMPH, lymphocyte. The data are presented as the mean ± SEM, *P < 0.05, ***P < 0.001, and ns indicates no significant difference.

Additional file 3: Fig. S3. Effects of cilostazol treatment on serum inflammatory factors. The level of serum TNF-α (a) and IL-1β (b) in each group (n = 6). The data are presented as the mean ± SEM, ***P < 0.001, ****P < 0.0001, and ns indicates no significant difference.

Additional file 3: Fig. S3. Effects of cilostazol treatment on serum inflammatory factors. The level of serum TNF-α (a) and IL-1β (b) in each group (n = 6). The data are presented as the mean ± SEM, ***P < 0.001, ****P < 0.0001, and ns indicates no significant difference.

Supplementary Material 3

Supplementary Material 2

Supplementary Material 3

Additional file 2.

Additional file 1: Fig. S1. DNA methylation level trends. (A) Bean plots showing the methylation level distribution of methylation sites in the context of CpG, CHG and CHH at genome wide scale. (B) The methylation level trends around gene features per sample. a = promoter (2 kb upstream of transcription start site); b = first exon; c = first intron; d = inner exons; e = inner introns; f = last exon; g = downstream...

Additional file 3: Fig. S3. Annotation of DMCs. (A-C) The annotation of DMCs in the context of CpG (A), CHG (B) and CHH (C). (D) The distribution of DMC CpG islands (CGIs) and related regions. (E-F) The number of DMCs grouped by the differences in methylation levels in gene features (E) and regions in CGI context (F).

Additional file 1: Supplementary Figure 1. Kaplan-Meiercurves of OS differences stratified by age, gender, tumor grade and stagebetween both groups in the entire TCGA set.

Additional file 5: Fig. S5. Effect of cilostazol treatment on cardiac function after CLP. a Representative M-mode images of the four different groups. b-e Quantitative analysis of LVEF (b), LVFS (c), LVEDD (d), and LVESD (e) in each group (n = 6). These data indicate no significant difference.

Additional file 5: Figure S1. Outliers detection in (A) training-validation set (GSE62254) and (B) TCGA dataset.

Additional file 3: Fig. S3. Verification of 5-HT2B knockout flies. (A) Molecular verification of 5-HT2B knockout flies by PCR analysis. Only one band was seen in w1118 controls, but a lower band could exist when a fragment of approximately 233 bp was deleted from the 5-HT2B locus. (B) The PCR-Sanger sequencing results of two reserved homozygous 5-HT2B knockout lines. The results show that the 5-HT2BKO_5-1 line has a 224 bp deletion in the first exon...

Additional file 5: Figure S5. Forest plot for adverse events at 4 weeks by concomitant medications.

Additional file 6: Figure S6. Forest plot for withdrawals due to adverse events in ADA and control groups

Supplemental material, sj-tif-3-cll-10.1177_09636897221139103 for Low-Dose Anti-Thymocyte Globulin Plus Low-Dose Posttransplant Cyclophosphamide as an Effective Regimen for Prophylaxis of Graft Versus Host Disease After Haploidentical Peripheral Blood Stem Cell Transplantation With Maternal/Collateral Related Donors by Ting Li, Qiaomei He, Jun Yang, Yu Cai, Chongmei Huang, Xiaowei Xu, Huiying Qiu, Jiahua Niu, Kun Zhou, Yin Zhang, Xinxin Xia, Yu Wei, Chang Shen, Xueying Ding, Yin Tong, Liping Wan and Xianmin Song in Cell Transplantation